These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36415369)
21. Glycosaminoglycans and mucopolysaccharidosis type III. Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513 [TBL] [Abstract][Full Text] [Related]
22. Klüver-Bucy syndrome associated with a recessive variant in HGSNAT in two siblings with Mucopolysaccharidosis type IIIC (Sanfilippo C). Hu H; Hübner C; Lukacs Z; Musante L; Gill E; Wienker TF; Ropers HH; Knierim E; Schuelke M Eur J Hum Genet; 2017 Feb; 25(2):253-256. PubMed ID: 27827379 [TBL] [Abstract][Full Text] [Related]
23. Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy. Ohmi K; Kudo LC; Ryazantsev S; Zhao HZ; Karsten SL; Neufeld EF Proc Natl Acad Sci U S A; 2009 May; 106(20):8332-7. PubMed ID: 19416848 [TBL] [Abstract][Full Text] [Related]
24. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells. Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609 [TBL] [Abstract][Full Text] [Related]
25. Clinical, biochemical, and molecular characterization of mucopolysaccharidosis type III in 34 Egyptian patients. Almenabawy N; Ramadan M; Kamel M; Mahmoud IG; Amer F; Shaheen Y; Elnaggar W; Selim L Am J Med Genet A; 2023 Sep; 191(9):2354-2363. PubMed ID: 37596900 [TBL] [Abstract][Full Text] [Related]
26. Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB. Meijer OLM; Welling L; Valstar MJ; Hoefsloot LH; Brüggenwirth HT; van der Ploeg AT; Ruijter GJG; Wagemans T; Wijburg FA; van Vlies N J Inherit Metab Dis; 2016 May; 39(3):437-445. PubMed ID: 26907177 [TBL] [Abstract][Full Text] [Related]
27. NAGLU mutations underlying Sanfilippo syndrome type B. Schmidtchen A; Greenberg D; Zhao HG; Li HH; Huang Y; Tieu P; Zhao HZ; Cheng S; Zhao Z; Whitley CB; Di Natale P; Neufeld EF Am J Hum Genet; 1998 Jan; 62(1):64-9. PubMed ID: 9443878 [TBL] [Abstract][Full Text] [Related]
28. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain. Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810 [TBL] [Abstract][Full Text] [Related]
29. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients. Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333 [TBL] [Abstract][Full Text] [Related]
30. Sanfilippo B in an elderly female psychiatric patient: a rare but relevant diagnosis in presenile dementia. Verhoeven WM; Csepán R; Marcelis CL; Lefeber DJ; Egger JI; Tuinier S Acta Psychiatr Scand; 2010 Aug; 122(2):162-5. PubMed ID: 20040070 [TBL] [Abstract][Full Text] [Related]
32. Polymorphic variants (p.Ser141Ser and p.Arg737Gly) at the NAGLU gene are really indicative of pseudodeficiency alleles? Rojas Malaga D; Leistner-Segal S; Brusius-Facchin AC Ital J Pediatr; 2019 May; 45(1):60. PubMed ID: 31088528 [TBL] [Abstract][Full Text] [Related]
33. Significant neuropsychiatric symptoms: three mucopolysaccharidosis type IIIB cases, two of whom were siblings with a novel NAGLU gene mutation. Değerliyurt A; Yayıcı Köken Ö; Teker ND; Aktaş D Neurocase; 2021 Aug; 27(4):366-371. PubMed ID: 34396902 [TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic features of 13 patients with mucopolysaccarhidosis type IIIB: Description of two novel Ozkinay F; Emecen DA; Kose M; Isik E; Bozaci AE; Canda E; Tuysuz B; Zubarioglu T; Atik T; Onay H Mol Genet Metab Rep; 2021 Jun; 27():100732. PubMed ID: 33747789 [TBL] [Abstract][Full Text] [Related]
35. What Can We Learn from the Parents of Children Affected with Mucopolysaccharidosis Type III-A in Israel? Liber S; Staretz-Chacham O; Kishon M; Pode-Shakked B; Chorin O; Kneller K; Anikster Y; Mangisto G; Saada A; Raas-Rothschild A Mol Syndromol; 2022 Feb; 13(1):45-49. PubMed ID: 35221874 [TBL] [Abstract][Full Text] [Related]
36. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Yogalingam G; Hopwood JJ Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611 [TBL] [Abstract][Full Text] [Related]
37. Long-term clinical course of a patient with mucopolysaccharidosis type IIIB. Kim JH; Chi YH; Kim GH; Yoo HW; Lee JH Korean J Pediatr; 2016 Nov; 59(Suppl 1):S37-S40. PubMed ID: 28018442 [TBL] [Abstract][Full Text] [Related]
38. Hemiatrophy of the spinal cord in a patient with mucopolysaccharidosis type IIIB. Samia P; Wieselthaler N; van der Watt GF; Wilmshurst JM J Child Neurol; 2010 Oct; 25(10):1288-91. PubMed ID: 20197271 [TBL] [Abstract][Full Text] [Related]
39. BMN 250, a fusion of lysosomal alpha-N-acetylglucosaminidase with IGF2, exhibits different patterns of cellular uptake into critical cell types of Sanfilippo syndrome B disease pathogenesis. Yogalingam G; Luu AR; Prill H; Lo MJ; Yip B; Holtzinger J; Christianson T; Aoyagi-Scharber M; Lawrence R; Crawford BE; LeBowitz JH PLoS One; 2019; 14(1):e0207836. PubMed ID: 30657762 [TBL] [Abstract][Full Text] [Related]
40. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. Cressant A; Desmaris N; Verot L; Bréjot T; Froissart R; Vanier MT; Maire I; Heard JM J Neurosci; 2004 Nov; 24(45):10229-39. PubMed ID: 15537895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]